INNOVADERM CRO IS NOW INDERO.

Podcast

FILTER BY:

Innovaderm to Indero
Podcast

Episode 33: Ana Palijan – Beyond Safety: The Evolving Complexity of Early Phase Studies

Innovaderm to Indero
Podcast

Episode 32: Sarah Ballard – Strategic Storytelling: The Role of PR in Biotech & Pharma Stakeholder Engagement

Innovaderm to Indero
Podcast

Episode 31: Ted Trafford and Brad Hightower – Dos and Don’ts for Sponsors and CROs in Site Collaborations – Part 3: Payments

Innovaderm to Indero
Podcast

Episode 30: Ted Trafford and Brad Hightower – Dos and Don’ts for Sponsors and CROs in Site Collaborations – Part 2: Focus on Protocol

Innovaderm to Indero
Podcast

Episode 29: Ted Trafford and Brad Hightower – Dos and Don’ts for Sponsors and CROs in Site Collaborations – Part 1: Site Engagement

Innovaderm to Indero
Podcast

Episode 28: MĂ©lanie Pomerleau – What is New With ICH E6 (R3)?

Innovaderm to Indero
Podcast

Episode 27: Beatriz Aguirre—How Genuine People Care Drives Business Success

Innovaderm to Indero
Podcast

Episode 26: Harley Skorpenske – Optimizing Recruitment & Retention in Rheumatoid Arthritis Clinical Trials

Innovaderm to Indero
Podcast

Episode 25: Lyn Mursalo and Randa Wahid – Navigating Global Clinical Trials: Strategies for Timelines, Communications, and Resilience

Subscribe to our Podcast.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.

Is Now

We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Additionally, our Clinical Research Unit (CRU) will keep the name Innovaderm and will continue to conduct dermatology studies.